The survival of DAM in ALS, despite CSF1R inhibition, may be due to decreased expression of Csf1r (Table S8) or rely on alternative survival pathways distinct from those in AD, potentially driven by the unique microenvironment of ALS. Here, CSF1R is linked to amyotrophic lateral sclerosis.